Taglutimide
Taglutimide (Biglumide; K 2004) is an orally active hypnotic agent. Taglutimide lowers plasma levels of diphenhydramine in rats and shortens the duration of anesthesia. Taglutimide is used in research on neurological disorders such as sedation and hypnosis.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 14166-26-8
- Formel: C14H16N2O4
- Molecular Weight:276.29
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Chemical Information
-
CAS. Nr. 14166-26-8
-
Molecular Weight 276.29
-
Formel C14H16N2O4
-
SMILES
O=C1NC(C(CC1)N2C(C3C(C4CCC3C4)C2=O)=O)=O
-
Synonyms
Biglumide; K 2004
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Jurecka W, et al. Teratologisch-neurotoxische Prüfung von Biglumid (K-2004) und Thalidomid [Teratologic-neurotoxicologic studies on biglumide (K-2004) and thalidomide]. Arch Toxicol. 1977 Jun 18;37(2):165-72. German. [Content Brief]
[2]. Wiener H, et al. Induction of drug metabolism in the rat by taglutimide, a sedative-hypnotic glutarimide derivative. Eur J Drug Metab Pharmacokinet. 1980;5(2):93-7. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)